683 Capital Management »

Vtv Therapeutics Inc Cl A shares owned by 683 Capital Management

Quarter-by-quarter ownership of Vtv Therapeutics Inc Cl A (VTVT) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Vtv Therapeutics Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including Vtv Therapeutics Inc Cl A held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vtv Therapeutics Inc Cl A by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $635k 16k 39.66
2025-12-31 $731k 18k 39.99

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
NVIDIA Corporation Put Option (NVDA)
Capital One Financial (COF)
Alnylam Pharmaceuticals (ALNY)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Tesla Motors Put Option (TSLA)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Praxis Precision Medicines I Com New Put Option (PRAX)
Wave Life Sciences SHS (WVE)
Becton, Dickinson and (BDX)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Vtv Therapeutics Inc Cl A

Samsara BioCapital
FMR
Millennium Management
Siren
Baker Bros. Advisors
Trails Edge Capital Partners
Vanguard Capital Management
Vanguard Group
Geode Capital Management
Vanguard Fiduciary Trust
Northern Trust
683 Capital Management
Goldman Sachs Group
BlackRock
Brevan Howard Capital Management

View all funds holding Vtv Therapeutics Inc Cl A